Home
#Global Trends
#Vietnam
#M&A
#Regulations
#Knowledge

Category: Uncategorized

BMS and Hengrui Pharma Form Multi-Billion Strategic Alliance for 13 Early-Stage Programs

14/05/2026 Published by vivi

Bristol Myers Squibb (BMS) and Hengrui Pharma have entered into a major global strategic collaboration to advance a portfolio of... Read more

Tags: #M&A

OrganaBio Acquires Excellos Assets to Establish Coast-to-Coast Cell Therapy CDMO

14/05/2026 Published by vivi

OrganaBio has announced the substantial acquisition of all operating assets from San Diego-based Excellos. This move officially establishes a bicoastal... Read more

Category: Uncategorized

Tags: #M&A

AstraZeneca Licenses Owkin’s AI Scientist to Develop Novel Biopharma Agents

14/05/2026 Published by vivi

AstraZeneca has entered into a three-year licensing agreement to integrate K Pro, Owkin’s "AI Scientist," into its IT infrastructure and... Read more

Category: Uncategorized

Tags: #Global Trends

EU Expands Indication for Pfizer’s Hympavzi to Treat Hemophilia A and B with Inhibitors

14/05/2026 Published by vivi

The European Commission (EC) has granted marketing authorization to expand the approved indication for Hympavzi (marstacimab). The expansion now covers... Read more

Category: Uncategorized

Tags: #Global Trends

Lilly’s Data Highlights ‘Maintenance’ Strategies for GLP-1 Weight Loss

14/05/2026 Published by vivi

Eli Lilly has released new data addressing a fundamental hurdle in obesity treatment: weight regain after discontinuing GLP-1 therapy. The... Read more

Category: Uncategorized

Tags: #Global Trends

Takeda Charts “New Era” with Global Restructuring and 4,500 Layoffs

14/05/2026 Published by vivi

Takeda Pharmaceutical is launching a comprehensive "Transformation Program" for fiscal year 2026 as it prepares for a leadership transition and... Read more

Category: Uncategorized

Tags: #Global Trends

BeOne’s Beqalzi Secures FDA Approval as New Challenger in the BCL-2 Market

14/05/2026 Published by vivi

BeOne Medicines has officially entered the BCL-2 landscape following the FDA’s accelerated approval of Beqalzi (sonrotoclax). This milestone marks the... Read more

Category: Uncategorized

Tags: #Global Trends

Leadership Divestment and Major Ownership Shift at Imexpharm Post-Acquisition

14/05/2026 Published by vivi

The Vietnamese pharmaceutical sector is witnessing significant transitions at Imexpharm Pharmaceutical JSC (IMP), following a major ownership transfer and a... Read more

Category: Uncategorized

Tags: #Vietnam